Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells

Area of Science:

• Molecular Biology
• Genetics
• Cardiovascular Science

Background:

• The let-7 family is a crucial microRNA group, highly expressed in the cardiovascular system.
• Aberrant expression of let-7 members is observed in numerous cardiovascular diseases, including hypertrophy, fibrosis, dilated cardiomyopathy (DCM), myocardial infarction (MI), arrhythmia, angiogenesis, atherosclerosis, and hypertension.
• Let-7 is involved in the cardiovascular differentiation of embryonic stem cells.

Purpose of the Study:

• To review the current research on the roles of the let-7 family in cardiovascular development.
• To summarize the involvement of let-7 in various cardiovascular diseases.
• To highlight the potential of let-7 as a therapeutic target for heart conditions.

Main Methods:

• Literature review of studies on let-7 in cardiovascular biology.
• Analysis of research linking let-7 expression patterns to cardiovascular disease states.
• Identification of known let-7 target genes and their relevance.

Main Results:

• let-7 family microRNAs are significantly implicated in cardiovascular development and disease pathogenesis.
• Specific let-7 members, like let-7b and let-7i, are potential biomarkers for acute myocardial infarction (MI) and dilated cardiomyopathy (DCM), respectively.
• Identified let-7 targets include TLR4, LOX-1, Bcl-xl, and AGO1, suggesting involvement in key signaling pathways.

Conclusions:

• let-7 microRNAs are critical regulators in cardiovascular development and disease.
• Further research is needed to fully elucidate let-7's gene targets and signaling pathways in cardiovascular diseases.
• The let-7 family represents a promising therapeutic target for managing cardiovascular diseases.